Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | BIIB | ARGX | ||
| Company | Horizon Therapeutics | Biogen Inc | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 215.30 | 395.00 | ||
| High | 116.38 | 217.88 | 397.18 | ||
| Low | 116.26 | 213.11 | 384.45 | ||
| Last | 116.30 | 217.51 | 388.20 | ||
| Change | +0.05 | +4.00 | -5.22 | ||
| % Change | +0.04% | +1.87% | -1.33% | ||
| Volume | 28,881,200 | 1,144,100 | 140,200 | ||
| 20-Day Average Volume | 3,994,490 | 1,344,250 | 227,090 | ||
| Previous Close | 116.25 | 213.51 | 393.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 203.10 | 375.95 | ||
| 20-Day Raw Stochastic | 95.09% | 95.41% | 77.34% | ||
| 20-Day Relative Strength | 80.29% | 56.41% | 53.52% | ||
| Weighted Alpha | +49.30 | -29.51 | -21.52 | ||
| Today's Opinion | 88% Buy | 56% Sell | 64% Sell | ||
| Previous Opinion | 88% Buy | 56% Sell | 48% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +4.12% since 04/26/24 | +4.13% since 04/26/24 | ||
| Low | 115.66 on 09/29/23 | 208.54 on 04/29/24 | 370.63 on 04/29/24 | ||
| High | 116.38 on 10/05/23 | 218.86 on 04/29/24 | 397.18 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +5.39% since 04/03/24 | -2.58% since 04/03/24 | ||
| Low | 114.75 on 09/11/23 | 189.44 on 04/19/24 | 357.55 on 04/19/24 | ||
| High | 116.38 on 10/05/23 | 218.86 on 04/29/24 | 397.18 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -10.75% since 02/02/24 | +2.47% since 02/02/24 | ||
| Low | 98.80 on 08/03/23 | 189.44 on 04/19/24 | 349.86 on 03/20/24 | ||
| High | 116.38 on 10/05/23 | 246.44 on 02/07/24 | 413.10 on 02/23/24 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | -12.82% since 11/03/23 | -22.35% since 11/03/23 | ||
| Low | 90.56 on 05/16/23 | 189.44 on 04/19/24 | 327.73 on 12/21/23 | ||
| High | 116.38 on 10/05/23 | 268.30 on 01/03/24 | 506.92 on 11/08/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 31,668,802 | 23,071,110 | ||
| Shares Outstanding, K | 228,995 | 145,597 | 59,431 | ||
| Annual Sales | 3,629,040,000 | 9,835,600,000 | 1,268,590,000 | ||
| Annual Net Income | 521,480,000 | 1,161,100,000 | -295,050,000 | ||
| Last Quarter Sales | 944,960,000 | 2,290,500,000 | 417,960,000 | ||
| Last Quarter Net Income | 127,070,000 | 393,400,000 | -99,170,000 | ||
| 60-Month Beta | 1.03 | -0.01 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 3.67 on 04/24/24 | -1.68 on 02/29/24 | ||
| Latest Earnings Date | 11/01/23 | 04/24/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 14.23 | 0.00 | ||